Atypical Antipsychotics

Impurity Paliperidone USP Related Compound D Applications One of the major degradation product of Risperidone in bulk drug and pharmaceutical dosage forms. Paliperidone USP Related Compound D. Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package References Leysen, J., et al.: J. Pharmacol. Exp. Ther., 247, 661 (1988), Huang, M., et al.: Pharm. Drug Dispos., 54, 257 (1993), Smyth, W., et al.: Anal. Bioanal. Chem., 378, 1305 (2004),

Applications Labelled Mesoridazine (M225760). Mesoridazine is an antipsychotic. References Rossato, G., et al.: ChemMedChem, 5, 2088 (2010), Sudeshna, G., et al.: Eur. J. Pharmacol., 648, 6 (2010), Hidaka, S., et al.: J. Toxicol. Sci., 35, 393 (2010),

Applications Antipsychotic. References Flanagan, T.L., et al.: J. Pharm. Sci., 51, 996 (1962), Post., A., et al.: Anal. Profiles Drug Subs., 9, 543 (1980)

Applications Labelled cis/trans-Chlorprothixene (C424850). Antipsychotic. Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package References Rudy, B.C., et al.: Anal. Profiles Drug Subs., 2, 63 (1973), Bagli, M., et al.: Arzneim.-Forsch., 46, 247 (1996),

Applications Risperidone (R525000) metabolite. References Meuldermans, W. et al.; Drug Metab. Dispos. 22, 129 (1994); Mannens, G. et al.; Drug Metab. Dispos. 21, 1134 (1993)

Applications An antipsychotic.A representative lot was 92% d8, 8% d7. Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package References Stille, et al: Farnaco, Ed. Prat., 26, 603 (1971), Hane, J.M., et al.: Psychopharmacol. Bull., 24, 62 (1988), Meltzer, H.Y.: J. Clin. Psychiatry, 55, Suppl. B, 47 (1994)

Applications Potential antipsychotic agent; antidopaminergic. References Hoegberg, T., et al.: J. Med. Chem., 33, 2305 (1990), 3) Glase, S., et al.: J. Med. Chem., 40, 1771 (1997), Hansch, C., et al.: Bioorg. Med. Chem., 11, 2075 (2003), Kulkarni, S., et al.: J. Med. Chem., 47, 3388 (2004), Verma, R., et al.: Bioorg. Med. Chem., 13, 1059 (2005),

Stability Hygroscopic Applications Dopamine receptor blocker; parent compound of sulforidazine and mesoridazine. Antipsychotic. Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package References Goldenthal, E.I., Toxicol. Appl. Pharmacol., 18, 185 (1971), Abdel-Moety, E.M., et al.: Anal. Profile Drug Subs., 18, 459 (1989),

Applications [4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidinyl]phenyl]cyclopropylmethanone is an impurity of Haloperidol (H103700), an antidyskinetic; antipsychotic. References Janicki, C.A., et al.: Anal. Profiles Drug Subs., 9, 341 (1980); Beresford, R., et al.: Drugs, 33, 31 (1987)

Applications The (R) optical isomer of Methotrimeprazine (M260785), an analgesic/neuroleptic. References Kandagal, P., et al.: J. Pharm. Biomed. Anal., 47, 260 (2008), Iorns, E., et al.: Biochem. J., 417, 361 (2009),

Stability Hygroscopic Applications Clothiapine, is a atypical antipsychotic of the dibenzothiazepine chemical class. It has shown efficacy in treatment-resistant schizophrenic patients. Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package References Schmutz, J., et al.: Helvetica Chimica Acta 50, 245 (1967); Geller, V., et al.: Schizophrenia Research 80 (2-3), 343 (2005);

Applications Labelled Perphenazine. D2 dopamine receptor antagonist; α-adrenergic receptor antagonist and σ-receptor agonist; phenothiazine antipsychotic. Inhibits glutamate dehydrogenase in vitro. Antipsychotic. References Gaertner, H.J., et al.: Drug Metab. Dispos., 3, 437 (1975), O Brien, S., et al.: J. Med. Chem., 48, 1287 (2005), Briggs, K., et al.: Toxicology, 231, 113 (2007), Toga, T., et al.: J. Pharmacol. Sci., 105, 207 (2007),

Applications Labelled Chlorpromazine (C424750). Used as an antiemetic; antipsychotic. Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package References Anden, N.-E., et al.: Eur. J. Pharmacol., 11, 303 (1970), Curzon, G., et al.: Trends Pharmacol. Sci., 11, 61 (1990),